Objective: To evaluate the risk factors for sentinel lymph node metastasis and validate the value of the Memorial Sloan -Kettering Cancer Center nomogram for the prediction of sentinel lymph node metastasis in breast cancer patients. Methods: A sentinel lymph node biopsy database containing 1227 consecutive breast cancer patients (416 patients with at least one positive sentinel lymph node) was retrospectively analyzed. The predictive value of the Memorial Sloan -Kettering Cancer Center nomogram was calculated by the trend line and the area under the receiver -operator characteristic curve. Meanwhile, predictors for sentinel lymph node metastasis were also evaluated. Results: Tumor size, histological grade, lymphovascular invasion, mulifocality, estrogen receptor and progesterone receptor status were significant independent predictors for sentinel lymph node metastasis (all P , 0.01). The Memorial Sloan -Kettering Cancer Center nomogram presented an area under the receiver -operator characteristic curve value of 0.730. Patients with predictive value ,16% had a frequency of sentinel lymph node metastasis of 0.9%. Those with values larger than 70% had a frequency of 96.2%. Conclusions: The risk factors for sentinel lymph node metastasis in our study were consistent with those in the Memorial Sloan -Kettering Cancer Center nomogram. The Memorial Sloan -Kettering Cancer Center nomogram is a useful tool that could accurately predict the probability of sentinel lymph node metastasis in our breast cancer patients. Axillary surgical staging might be avoided in patients with a predictive value of ,16% and axillary lymph node dissection might be done directly in those with a predictive value .70%, while other patients should still accept sentinel lymph node biopsy.
INTRODUCTION
The contemporary approach for detecting axillary metastases in clinically node-negative patients with early-stage breast cancer is intraoperative lymphatic mapping and sentinel lymph node biopsy (SLNB), a minimally invasive and a highly accurate staging procedure (1 -4) . The early and late postoperative morbidity of SLNB is significantly lower than that of axillary dissection, but lymphedema occurs in 5% of patients. The postoperative complications and relative medical burden of SLNB could not be neglected. Bevilacqua et al. (5) have developed a nomogram to help estimate the risk of sentinel lymph node (SLN) metastasis. The nomogram developed in the Memorial Sloan-Kettering Cancer Center (MSKCC) is based on nine factors, which were found to be predictive: age, tumor size, tumor type, tumor location, lymphovascular invasion, mulifocality, histologic grade, estrogen receptor (ER) and progesterone receptor (PR) status. Retrospective data were used to create the model, which was tested prospectively at MSKCC to be predictive of SLN metastasis. The area under the receiver-operator characteristic curve (AUC) was 0.754 in the validation data. This study evaluated the risk factors for SLN metastasis and validated the value of the MSKCC nomogram for the prediction of SLN metastasis in China.
PATIENTS AND METHODS

PATIENTS
A SLNB database containing 1227 consecutive breast cancer patients (416 patients with at least one positive SLN) was retrospectively analyzed. The average age was 48.16 years (range, 21 -83). The inclusion criteria were invasive breast cancer, clinically axilla negative, no previous ipsilateral axillary surgery and no neoadjuvant chemotherapy. The study was approved by the ethics committee and each patient provided informed consent.
IDENTIFICATION AND DIAGNOSIS OF SLNS
99m Tc-labeled sulfur colloid ( 99m Tc-SC) was injected subcutaneously above the primary tumor or around the biopsy cavity 3 -18 h prior to surgery and lymphoscintigraphy was performed 30 min before surgery (6, 7) . After a successful anesthesia, 2 -4 ml of 1% of methylthioninium was similarly injected. SLNs were identified with the use of intraoperative gamma detector (Neoprobe, Neo2000 gamma detection system, Johnson and Johnson) in combination with blue dye. The fresh tissue containing the SLNs was submitted for intraoperative pathological examination by touch imprint cytology (TIC) and frozen section. TIC was then performed from alternative cut surfaces on a glass slide and the whole material was then submitted to frozen section. Then, patients underwent only SLNB if SLNs were negative and axillary lymph node dissection (ALND) was performed consequently if SLNB was failure or SLNs were positive.
METHODS OF STATISTICS
The data were analyzed with the SPSS 17.0 software package. The x 2 test or Fisher's exact test was performed to compare the rates between different groups, and the t-test or the Mann -Whitney test was used to compare the difference in means between groups. P value was considered significant when ,0.05. A multivariable logistic regression analysis was performed to determine the independent predictive effect.
MSKCC NOMOGRAM ANALYSIS
The predicted probability of SLN metastasis was calculated for each patient with the computerized model on the MSKCC website (http://www.mskcc.org/mskcc/html/ 15938.cfm), and the details of the MSKCC nomogram and internal validation could be found on the aforementioned website and the relative publication (5) . The discriminatory accuracy of the MSKCC nomogram was estimated by constructing receiver operating characteristics (ROC) curves and measuring AUC. AUC has an inferior accuracy between 0.5 and 0.7, a superior accuracy between 0.7 and 0.9 and an excellent discrimination over 0.9, and AUC ¼ 0.5 is equal to the toss of a coin. (Table 1) . By multivariate analysis, tumor size, histological grade, lymphovascular invasion, mulifocality, ER and PR status were significant independent predictors for SLN metastasis (Table 2 ).
THE CUT-OFF VALUE OF MSKCC NOMOGRAM
With the MSKCC nomogram, the predicted probability of SLN metastasis was calculated for each patient. In this study, the patients with a predictive value of ,16% had a frequency of SLN metastasis of 0.9%, those with values larger than 70% had a frequency of 96.2%. The performance of the MSKCC nomogram was assessed in our data set and the 11 -20% predicted probability cut-off values are shown in Tables 3 and 4 .
THE ACCURACY OF THE MSKCC NOMOGRAM
In this study, all the 1227 patients received SLNB, 52 of them were special types (including medullary carcinomas, mucinous carcinomas and tubular carcinoma). The classical groups of the MSKCC nomogram and the validation groups of Freiburg were compared with our population (Table 5 ). In order to estimate the accuracy of the MSKCC nomogram in our data set, we drew a trend line according to the true value of SLN metastasis and predictive value. Consequently, the two curves had the same trend and had no obvious deviation ( Fig. 1 ). In addition, the AUC for our study population was 0.730 ( Fig. 2 ).
DISCUSSION
SLNs have been the standard procedure for the staging of axilla in order to decrease the surgical morbidity of ALND. However, the side effects of SLNB without consecutive ALND should not be neglected. In the NSABP B-32 trial, a comparison of 3-year post-surgical morbidity levels between patients with negative SLNB and those with a negative SLNB and negative ALND, the percentage of patients in the SLNB group who had relative shoulder abduction deficits 10% peaked at 41% at 1 week, arm volume differences 10% (8%) at 36 months and numbness (15%) and tingling (10%) peaked at 6 months (8). The ACOSOG Z0010 trial had also shown the complications of SLNB, anaphylaxis (0.1%), seroma (7.1%) and wound infection (1.4%) (9) . Furthermore, SLNB would bring more waste of medical resources, especially in cases of patients with a very low or (11 -20) . Others did not find good correlation, in particular with micrometastatic disease (21, 22) . Recently, it was reported that this nomogram was of no value with the result of Z0011 included in the 2012 National Comprehensive Cancer Network Clinical Practice Guidelines. It was suggested that SLNB without ALND could offer excellent regional control and might be reasonable management for selected early-stage breast cancer patients with two or more positive SLNs treated with breastconserving therapy and adjuvant systemic therapy (23) .
The MSKCC SLNs nomogram developed by Bevilacqua in 2007 can only be validated in German Freiburg (24) . As a new statistical approach that allows the calculation of SLN metastatic risk by combining different clinicopathological prognostic factors, the MSKCC nomogram was developed to provide both clinicians and patients with information that helps to decide on the worthiness of SLNB. To our knowledge, this is the first validation study of the MSKCC nomogram focused on the likelihood of SLN metastasis in a Chinese breast cancer population, and the results of our study support a predictive accuracy in china with a statistically significant AUC c-statistic value of 0.730. This means that if we randomly select two patients, of whom one has at least one positive SLN and the other has negative SLNs, there is a 73% chance that the nomogram will predict a higher probability for the positive one.
The composition of the study group researched by our center was mainly the same as that of the MSKCC classic population and the Germanic population (Table 5) . It is noteworthy that the ratios of lymphovascular invasion and multifocality in our center were much lower than that in the other two centers. It was reported that the ratio of multifocality of Chinese breast cancers is much lower than that in most of Western countries (25) . Although the lymphovascular invasion and the mulifocality were two independent risk factors for SLN metastasis, they did not take a significant proportion in the MSKCC nomogram. This kind of difference did not affect the application of the MSKCC nomogram in Chinese populations.
Age, tumor size, tumor type, lymphovascular invasion, tumor location, multifocality and ER and PR were associated with SLN metastasis in multivariate analysis in MSKCC (5) . In Klar's collective (24) , tumor size, tumor type, lymph vascular invasion, multifocality, HER2 and histological grade correlated with the probability of SLN metastasis. Moreover, as many studies have also reported, age, tumor size, lymph vascular invasion and histological grade were the independent factors for SLN metastasis (26) . In our study, logistic regression was used to analyze the association of each variable with the likelihood of SLN metastasis, and we found that tumor size, histological grade, lymphovascular invasion, mulifocality, ER and PR were significant independent predictors. This result had also supported the variable in the MSKCC nomogram indirectly.
In our analyses, the MSKCC nomogram is a useful tool that could accurately predict the probability of SLN metastasis in early breast cancer patients. The patients with a predictive value of very high or very low probability of SLN metastasis are unlikely to benefit from SLNB but result in higher costs and postoperative morbidity. Several studies have shown that axillary surgery could be avoided when the MSKCC predictive value is ,10%, but the clinical ultility of this standard is limited because the ratio of beneficial patients is lower among the SLNB crowds (average ,5%). In this study, patients with a predictive value ,16% had no SLN metastasis. When the predictive value equaled 16%, the positive rate of SLNs was merely 5.9%, compared with the false-negative rate of SLNs of 8.4% (0-29%) that ASCO reported (27) , which we could consider to avoid axillary node dissection either. Patients with predictive values larger than 70% had a frequency of SLN metastasis of 96.2%, and they could carry out ALND directly. We considered that a risk of SLN involvement of 16% or 70% was an acceptable cut-off value to select candidates who may avoid SLNB with the MSKCC nomogram, and 12.8% (157/1227) of patients could benefit from the new standard.
The best statistic tool is when the AUC is near 1, so the MSKCC nomogram (AUC ¼ 0.730 -0.780) should be improved. Reyal et al. (28) found that the interaction covariate between ER and HER2 status was a stronger predictor (P ¼ 0.0031) of positive sentinel node biopsy than the ER status by itself (P ¼ 0.016). They have developed a multivariate model to determine the probability of SLN positivity defined with the following variables: tumor size, lymphovascular invasion, molecular subtypes and age at diagnosis. This model showed similar results in terms of discrimination (AUC ¼ 0.72/0.73/0.72) in the training and validation sets.
The MSKCC nomogram is a free network auxiliary approach that allows the calculation of SLN metastatic risk by combining different histopathological prognostic factors. The predictive model was developed to provide both clinicians and patients with valuable references that help decide on the worthiness of SLNB. We have performed a validation of the MSKCC nomgram for the prediction of SLN metastasis in a Chinese breast cancer population. In our analysis, the MSKCC nomogram is a useful tool that could accurately predict the probability of SLN metastasis, but should be improved to be valid and definitive. Although our data have approved that the nomogram does have a better predictive value, we do not assert that it can be an alternative to SLNB. Probably, patients who benefit the most from the nomogram would be those with a very low or high risk of SLN metastasis. Since our results have been obtained from the retrospective analysis, a randomized prospective validation should be performed for the MSKCC nomogram in order to assess its ability for preoperative discrimination.
